Pletaxol Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Cilostazol

Indications/Uses

Management of peripheral vascular disease, often for atherosclerotic or occlusive arterial disease but covers both arterial & venous disorders & may be due to atherosclerosis, vasospasm or thromboembolism.

Click to view Pletaxol detailed prescribing information

Dosage/Direction for Use

50 mg or 100 mg bid. Response to treatment may occur in 2-4 wk, but up to 12 wk may be required.

Click to view Pletaxol detailed prescribing information

Overdosage

View Pletaxol overdosage for action to be taken in the event of an overdose.

Administration

Should be taken on an empty stomach: Take at least 30 min before or 2 hr after meals.

Contraindications

Hypersensitivity. Patients w/ CHF of any severity; known predisposition to bleeding, history of ventricular arrhythmias, QT interval prolongation, severe renal impairment or moderate to severe hepatic impairment.

Click to view Pletaxol detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Pletaxol detailed prescribing information

Special Precautions

Avoid use or reduce dose in patients taking CYP3A4 or CYP2C19 inhibitors. Pregnancy.

Click to view Pletaxol detailed prescribing information

Use In Pregnancy & Lactation

Click to view Pletaxol detailed prescribing information

Adverse Reactions

Headache, dizziness, palpitations, diarrhoea; oedema, nausea & vomiting, other cardiac arrhythmias, chest pain, rhinitis, ecchymosis, skin rashes.

Click to view Pletaxol detailed prescribing information

Drug Interactions

Concomitant use w/ other drugs that inhibit or are metabolized by CYP3A4 or CYP2C19 may result in changes in plasma conc of cilostazol or the concomitant drug & possibly adverse effects.

Click to view Pletaxol detailed prescribing information

Storage

View Pletaxol storage conditions for details to ensure optimal shelf-life.

Description

View Pletaxol description for details of the chemical structure and excipients (inactive components).

Action

View Pletaxol mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

ATC Classification

B01AC23 - cilostazol ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis.

Regulatory Classification

Presentation/Packing

Form

Pletaxol tab 100 mg

Packing/Price

30's

Form

Pletaxol tab 50 mg

Packing/Price

30's

Pletaxol

cilostazol

Manufacturer:

Lloyd

Distributor:

InnoGen Pharmaceuticals